“Edible” describes a product format, not a particular cannabinoid or legal status. Gummies, chocolates and drinks can differ widely in their ingredients and concentrations. Before using one, establish what it contains, what the label means and whether it is lawfully available for the intended use.
THC and CBD are different
THC is intoxicating and can impair coordination and judgement. CBD does not produce the same high, but it is not automatically free of side effects or medicine interactions. A CBD label also needs evidence about any THC present; the product name alone is not a laboratory result.
Terms such as full-spectrum, hemp or natural do not tell you a serving’s THC or CBD content. Look for separate quantities for the individual cannabinoids.
Per piece, per serving and per pack
Check whether the stated milligrams apply to one piece, one serving or the whole container. For example, a hypothetical pack labelled 100 mg CBD across 20 equal gummies contains 5 mg CBD per gummy, assuming the label accurately describes uniform content. This is label arithmetic, not a recommended dose.
Also check whether a serving is one whole item or part of it, along with the ingredients, allergens, batch details, expiry information and storage directions. If the units or serving information are unclear, ask the supplier before use.
Look beyond the large number on the front
A package can state an amount of hemp extract without stating the amount of each cannabinoid. Those figures are not interchangeable. A useful label identifies the named substances and explains the unit clearly enough that the amount per piece or serving can be understood.
Consider a second hypothetical label: 30 pieces, two pieces per serving and 300 mg CBD in the whole pack. That means 15 labelled servings and, assuming uniform content, 20 mg CBD per serving. The two-piece serving matters; dividing only by the number of servings or only by the number of pieces answers different questions. None of these numbers is a suggested dose.
A batch certificate can help verify composition when it matches the product and lot number. Check which substances were actually tested and the laboratory’s reporting limits. A generic report, an undated screenshot or a certificate for a different batch should not be treated as confirmation of the contents in your hand.
Also read the ordinary food information: allergens, other added ingredients and storage instructions still matter. A cannabis-themed design does not make those details less relevant, and a medicinal-looking package does not prove that the item is an authorised medicine.
Why delayed effects matter
Health Canada advises that ingested cannabis effects can begin after 30 minutes to two hours, while full effects may take up to four hours. Individual timing varies. Taking more because little is felt early on can lead to unexpectedly strong effects later.
Effects can last for many hours. Follow product-specific instructions, avoid rapid repeat consumption and do not interpret an early lack of effects as proof that the product is weak. Do not combine intoxicating edibles with alcohol, drive or operate machinery.
Storage and adverse reactions
Keep products in their original, clearly labelled packaging and locked away from children and pets. Gummies and chocolates can easily be mistaken for ordinary sweets.
If someone develops severe confusion, breathing difficulty, chest pain or becomes unresponsive, seek urgent medical help. Suspected ingestion by a child warrants prompt medical advice; keep the packaging available so professionals can identify the contents.
Why a familiar format can be misleading
A sweet, biscuit or drink can look like an ordinary snack while carrying a very different risk. Keep the original packaging and avoid transferring pieces to an unlabelled jar or sharing them without a clear explanation of their contents. Guests and family members should never have to infer what a product contains from its appearance.
Malta’s ARUC also highlights delayed onset and the risk of taking more too early. Timing information describes a range, not a countdown that guarantees safety. Food intake, the formulation and individual response can change the experience; previous use of an inhaled product does not establish how an edible will affect someone.
If a product’s contents cannot be established, do not use trial and error to work them out. Seek reliable product information instead. If someone feels unwell, stop further consumption, stay with them and obtain medical advice when needed. Do not let an impaired person drive themselves for help.
Europe does not have one edible-cannabis rule
Rules depend on the country, cannabinoid, composition and product category. In the EU, CBD and other cannabinoid food products can fall within the Novel Food framework; an application or appearance in a catalogue is not itself a marketing authorisation. The official Union list and any applicable national requirements must be checked for the specific product.
A low THC percentage alone does not establish that a food can lawfully be sold. Likewise, permission to possess cannabis in one country is not permission to import it, buy it commercially or carry it across a border. Check the destination’s current official guidance before travelling.
What changed in EU CBD safety advice in 2026?
In February 2026, EFSA set a provisional safe intake level for certain CBD food-supplement formulations of 0.0275 mg per kilogram of body weight per day, approximately 2 mg for a 70 kg adult. Its scope is narrow: CBD purity of at least 98%, no nanoparticles, and production conditions meeting the stated safety criteria. EFSA could not establish safety for people under 25, pregnant or breastfeeding women, or people taking medicines.
This is a scientific safety assessment with remaining data gaps, not a recommended treatment dose, a general limit applicable to every edible, or a product marketing authorisation. A low number on a pack does not itself prove compliance. Check the current Union list and relevant national requirements for the exact product rather than assuming a scientific opinion has authorised it.
A sensible check before purchase
- Identify the exact cannabinoid and its quantity per piece, serving and pack.
- Check whether the intended use and sale are permitted where you are.
- Read the full ingredients, warnings and batch information.
- Plan secure storage away from children and pets.
- Keep health and medicine questions separate from promotional claims.
For medicine interactions, pregnancy, health conditions or prescribed cannabinoid treatment, seek individual professional advice rather than following a generic online dosing table.
For the wider distinction between chemical composition and demonstrated effects, see our guide to cannabinoid and terpene evidence.
Sources and further reading
- Health Canada: onset, delayed full effects and storage
- Health Canada: consumer information
- European Commission: cannabinoid Novel Food statement
- European Commission: Union list of authorised novel foods
- EFSA: provisional CBD safe intake level, February 2026
- ARUC: consumption methods and delayed onset
Content reviewed on 18 October 2026.
